source
- China biotech RiboX reports first human data for circular RNA therapiesChina biotech company RiboX has disclosed its initial human data on circular RNA therapeutics, marking the first clinical readout for this emerging platform. The study represents a milestone for t…
- Samsung Biologics union vows appeal after court blocks planned strikeA Seoul court granted Samsung Biologics an order that prevents its labor union from holding a strike that had been scheduled for the company's bio-manufacturing campus. The union, representing con…